[1]郭江涛综述,邓靖宇审校.胃癌淋巴结转移的分子标志物研究进展[J].天津医科大学学报,2017,23(01):85-89.

点击复制

胃癌淋巴结转移的分子标志物研究进展(PDF)

分享到：

参考文献/References:

[1]邹文斌，李兆申．中国胃癌发病率及死亡率研究进展[J]．中国实用内科杂志，2014，34（4）：408

[2]Degiuli M, Borasi A, Forchino F, et al. Lymph-nodal ratio in gastric cancer staging system[J]. Minerva Chir, 2011, 66(3): 177

[3]Corso G, Marrelli D, Roviello F. Familial gastric cancer and germline mutations of E-cadherin[J]. Ann Ital Chir, 2012, 83(3): 177

[4]Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer[J]. Am J Pathol, 2002, 161(5): 1881.

[5]Castro Alves C, Rosivatz E, Schott C, et al. Slug is overexpressed in gastric carcinomas and May act synergistically with SIP1 and Snail in the down-regulation of E-cadherin[J]. J Pathol, 2007, 211(5): 507

[6]Graziano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice[J]. Ann Oncol, 2003, 14(12): 1705

[7]Li Y, Chen C Q, He Y L, et al. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma[J]. J Surg Oncol, 2012, 106(3): 304

[8]Krause T, Turner G A. Are selectins involved in metastasis?[J]. Clin Exp Metastasis, 1999, 17(3): 183

[9]Ke J J, Shao Q S, Ling Z Q. Expression of E-selectin, integrin beta1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance[J]. World J Gastroenterol, 2006, 12(22): 3609

[10]Dai Ni, Bao Quan, Lu A, et al. Protein expression of osteopontin in tumor tissues is an Independent prognostic indicator in gastric cancer[J]. Oncology, 2007, 72(1/2): 89

[11]Weber G F, Zawaideh S, Hikita S, et al. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation[J]. J Leukoc Biol, 2002, 72(4): 752

[12]Song Gang, Ouyang Gaoliang, Mao Yubin, et al. Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation[J]. J Cell Mol Med, 2009, 13(8B): 1706

[13]Barczyk M, Carracedo S, Gullberg D. Integrins[J]. Cell Tissue Res, 2010, 339(1): 269

[14]Zhao Zhong SHENG, Wang Yuan YU, Chu Yong QUAN, et al. SPARC is associated with gastric cancer progression and poor survival of patients[J]. Clin Cancer Res, 2010, 16(1): 260

[15]Mori M, Shimada H, Gunji Yoshio, et al. S100A11 gene identified by in-house cDNA microarray as an accurate predictor of lymph node metastases of gastric cancer[J]. Oncol Rep, 2004, 11(6): 1287

[16]Kleiner D E, Stetler-Stevenson W G. Matrix metalloproteinases and metastasis[J]. Cancer Chemother Pharmacol, 1999, 43(1): S42

[17]Wu Chun YING, Wu M S, Chen Yi JU, et al. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer[J]. Eur J Cancer, 2007, 43(4): 799

[18]Sentani K, Matsuda M, Oue N, et al. Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma[J]. Gastric Cancer, 2014, 17(3): 412

[19]Zhang J F, Zhang Y P, Hao F Y, et al. DNA ploidy analysis and expression of MMP-9, TIMP-2, and E-cadherin in gastric carcinoma[J]. World J Gastroenterol, 2005, 11(36): 5592

[20]Ma Xiu MEI, Shen Zhi HUA, Liu Zhi YAO, et al. Heparanase promotes human gastric cancer cells migration and invasion by increasing Src and p38 phosphorylation expression[J]. Int J Clin Exp Pathol, 2014, 7(9): 5609

[21]Vlodavsky I, Elkin M, Pappo O, et al. Mammalian heparanase as mediator of tumor metastasis and angiogenesis[J]. Isr Med Assoc J, 2000, 2(Suppl): 37

[22]Harbeck N, Schmitt M, Meisner C, et al. Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients[J]. Eur J Cancer, 2013, 49(8): 1825

[23]Kaneko T, Konno H, Baba Megumi, et al. Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer[J]. Cancer Sci, 2003, 94(1): 43

[24]Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis[J]. Nature, 2001, 410(6824): 50

[25]Mashino K, Sadanaga N, Yamaguchi H, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma[J]. Cancer Res, 2002, 62(10): 2937

[26]Kryczek I, Wei Shuang, Keller E, et al. Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis[J]. Am J Physiol Cell Physiol, 2007, 292(3): C987

[27]Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4[J]. Semin Cancer Biol, 2004, 14(3): 171

[28]Sugasawa H, Ichikura T, Kinoshita M, et al. Gastric cancer cells exploit CD4+ cell-derived CCL5 for their growth and prevention of CD8+ cell-involved tumor elimination[J]. Inter J Cancer, 2008, 122(11): 2535

[29]Eck M, Schmausser B, Scheller K, et al. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma[J]. Clin Exp Immunol, 2003, 134(3): 508

[30]Wei Lu MIN, Cao Shan, Yu Wei DONG, et al. Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer[J]. Oncol Rep, 2015, 33(2): 615

[31]Hu Min, Li Kai, Maskey N, et al. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer[J]. Hum Pathol, 2015, 46(12): 1872

[32]Nakamura Y, Yasuoka H, Tsujimoto M, et al. Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early stage cancer[J]. J Clin Pathol, 2006, 59(1): 77

[33]Watanabe M, Tanaka H, Ohira M, et al. Intranodal lymphangiogenesis precedes development of lymph node metastasis and accelerates progression of gastric cancer[J]. J Gastrointest Surg, 2014, 18(3): 481

[34]Han F H, Li H M, Zheng D H, et al. The effect of the expression of vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 on the clinical outcome in patients with gastric carcinoma[J]. Eur J Surg Oncol, 2010, 36(12): 1172

[35]Wang X L, Fang J PI, Tang R Y, et al. Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases[J]. BMC Cancer, 2010, 10: 299

[36]Deng J Y, Liang H, Sun D, et al. Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy[J]. Surgery, 2009, 146(5): 896

[37]Deng J Y, Liang H, Sun D, et al. Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy[J]. World J Gastroenterol, 2008, 14(15): 2440

[38]Mrena J, Wiksten J P, Thiel A, et al. Cyclooxygenase-2 is an Independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR[J]. Clin Cancer Res, 2005, 11(20): 7362

[39]Su J L, Shih J Y, Yen M L, et al. Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma[J]. Cancer Res, 2004, 64(2): 554

[40]Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more[J]. Nat Rev Mol Cell Biol, 2003, 4(12): 915

[41]Tanaka K, Miki C, Wakuda R, et al. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma[J]. Scand J Gastroenterol, 2004, 39(8): 754

相似文献/References:

[1]刘新兰,李淑璟,张海霞.候选抑癌基因RASSF6在胃癌组织中的表达及其与临床病理特征的关系[J].天津医科大学学报,2015,21(04):287.
　LIU Xin -lan,LI Shu -jing,ZHANG Hai -xia.Expressions of RASSF6 in gastric cancer and its association with clinicopathologic feature[J].Journal of Tianjin Medical University,2015,21(01):287.
[2]李 静,孙保存,孙 冉,等.环氧合酶2通过上皮间质转换促进胃癌的侵袭与转移 [J].天津医科大学学报,2016,22(03):185.
　LI Jing,SUN Bao-cun,SUN Ran,et al.Cyclooxygenase-2 promotes gastric cancer invasion and metastasis by inducing epithelial to mesenchymal transition[J].Journal of Tianjin Medical University,2016,22(01):185.
[3]赵忠治,王金淼,魏颖,等.术前外周血NLR与PLR对胃癌预后的评估价值[J].天津医科大学学报,2018,24(01):50.
　ZHAO Zhong-zhi,WANG Jin-miao,WEI Ying,et al.Evaluation value?of preoperative peripheral blood NLR and PLR? on prognosis of? gastric cancer[J].Journal of Tianjin Medical University,2018,24(01):50.
[4]张 悦,管叙文,王婧雅,等.miR-27a对胃癌细胞凋亡影响的体外研究[J].天津医科大学学报,2018,24(06):469.
　ZHANG Yue,GUAN Xu-wen,WANG Jing-ya,et al.Influence of miR-27a on apoptosis of gastric cancer cells in vitro[J].Journal of Tianjin Medical University,2018,24(01):469.
[5]张灿灿,谭志军.FMNL2在胃癌组织中的表达及其临床意义[J].天津医科大学学报,2020,26(02):149.
　ZHANG Can-can,TAN Zhi-jun.Expression and clinical significance of FMNL2 in gastric cancer[J].Journal of Tianjin Medical University,2020,26(01):149.
[6]赵珍珍 综述,邓靖宇 审校.蛋白质组学技术在胃癌研究中的应用[J].天津医科大学学报,2021,27(01):94.
[7]昕宇 综述,邓靖宇,梁寒 审校.主动脉旁淋巴结清扫术在进展期胃癌治疗中的研究进展[J].天津医科大学学报,2021,27(01):99.
[8]左兴盛,宋志玉,贾海盼,等.沉默circPVT1对5-氟尿嘧啶耐药胃癌细胞化疗增敏作用及机制研究[J].天津医科大学学报,2021,27(06):574.
　ZUO Xing-sheng,SONG Zhi-yu,JIA Hai-pan,et al.The sensitizing effect and mechanism of silencing of circPVT1 on 5-fluorouracil chemosensitivity in gastric cancer cells[J].Journal of Tianjin Medical University,2021,27(01):574.
[9]赵路瑶 综述,李慕然,刘艳迪 审校.外周血SEPT9基因甲基化检测在胃癌诊断中的研究进展[J].天津医科大学学报,2022,28(02):218.
[10]胡逸恺,宋明坤,王旭东,等.单细胞转录组探究胃癌转移过程中MHC-Ⅱ类分子的演进缺失[J].天津医科大学学报,2023,29(01):1.
　HU Yi-kai,SONG Ming-kun,WANG Xu-dong,et al.Single-cell transcriptome analysis revealed the evolutionary deletion of MHC-Ⅱ expression in gastric cancer metastasis[J].Journal of Tianjin Medical University,2023,29(01):1.
[11]白惠惠,邓靖宇,梁 寒.血清肿瘤标志物对胃癌淋巴结转移的诊断价值[J].天津医科大学学报,2019,25(03):241.
　BAI Hui-hui,DENG Jing-yu,LIANG Han.Prognostic value of serum tumor biomarkers for lymph node metastasis of gastric cancer[J].Journal of Tianjin Medical University,2019,25(01):241.

备注/Memo

备注/Memo:

基金项目 国家自然科学基金资助项目（81572372）；天津市科委应用基础与前沿技术研究计划项目(15JCYBJC24800)；天津市科委重点项目（13ZCZCSY20300）

作者简介 郭江涛（1989-），男，硕士在读，研究方向：胃癌淋巴结转移机制研究；通信作者：邓靖宇，dengery@126.com。

常用功能